Home › Research › Down syndrome and Alzheimer's
Alzheimer-type neuropathology and clinical symptoms of dementia in mentally retarded people without Down syndrome
Barcikowska M, Silverman W, Zigman W, Kozlowski PB, Kujawa M, Rudelli R, Wisniewski HM.. American journal of mental retardation : AJMR, 1989-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Postmortem morphometric analyses of Bielschowsky stained sections from brains of 70 mentally retarded people without Down syndrome, age 65 and over when they died, indicated Alzheimer-type neuropathology in 22 cases (31%) and a majority with at least presence of some Alzheimer-type lesions. Based upon information abstracted from clinical histories, however, old-age-associated dementia proved to be difficult to judge reliably. Nevertheless, for otherwise healthy individuals (n = 25), loss of motor skills, development of problem behaviors, and a 10-point drop in IQ appeared to be likely indicators of Alzheimer's disease. Prevalence estimates of Alzheimer-type neuropathology among nonretarded people and the present sample appear comparable, and projections must be made to address the special needs of this rapidly growing population of retarded people.
What this study adds
Evidence grade: Low
The record lists 25 participants. This postmortem study found Alzheimer-type neuropathology in 31% of mentally retarded people without Down syndrome aged 65 and over, and identified possible clinical indicators of Alzheimer's disease in otherwise healthy individuals. It describes prevalence and symptoms but does not test any treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Barcikowska, M., Silverman, W., Zigman, W., Kozlowski, P. B., Kujawa, M., Rudelli, R., et al. (1989). Alzheimer-type neuropathology and clinical symptoms of dementia in mentally retarded people without Down syndrome. American journal of mental retardation : AJMR.
Vancouver
Barcikowska M, Silverman W, Zigman W, Kozlowski PB, Kujawa M, Rudelli R, et al. Alzheimer-type neuropathology and clinical symptoms of dementia in mentally retarded people without Down syndrome. American journal of mental retardation : AJMR. 1989. PMID: 2706124.
BibTeX
@article{barcikowska1989-2706124,
author = {Barcikowska, M. and Silverman, W. and Zigman, W. and Kozlowski, P. B. and Kujawa, M. and Rudelli, R. and Wisniewski, H. M.},
title = {{Alzheimer-type neuropathology and clinical symptoms of dementia in mentally retarded people without Down syndrome}},
journal = {American journal of mental retardation : AJMR},
year = {1989},
pmid = {2706124}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Postmortem morphometric analyses of Bielschowsky stained sections from brains of 70 mentally retarded people without Down syndrome, age 65 and over when they died, indicated Alzheimer-type neuropathology in 22 cases (31%) and a majority with at least presence of some Alzheimer-type lesions.
- Based upon information abstracted from clinical histories, however, old-age-associated dementia proved to be difficult to judge reliably.
- Nevertheless, for otherwise healthy individuals (n = 25), loss of motor skills, development of problem behaviors, and a 10-point drop in IQ appeared to be likely indicators of Alzheimer's disease.
- Prevalence estimates of Alzheimer-type neuropathology among nonretarded people and the present sample appear comparable, and projections must be made to address the special needs of this rapidly growing population of retarded people.
Why it matters
This postmortem study found Alzheimer-type neuropathology in 31% of mentally retarded people without Down syndrome aged 65 and over, and identified possible clinical indicators of Alzheimer's disease in otherwise healthy individuals. It describes prevalence and symptoms but does not test any treatment or prevention.
Study details
- Participants25
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record and institution's track record, so those were left out: it earned 33 of the 93 points we could judge it on, which is 35 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (American journal of mental retardation : AJMR) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1989 — older than 20 years, still counted |
| Sample size | 1 / 4 | 25 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 39 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 39 year(s) since 1989 |
| Impact for its field and year | 2 / 6 | Cited 1.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Henryk M. Wisniewski: h-index 40 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 2706124) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 33 / 93 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 33 of the 93 points we could judge it on is 35 out of 100. |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.